1. Home
  2. SDSTW vs VRAX Comparison

SDSTW vs VRAX Comparison

Compare SDSTW & VRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stardust Power Inc. Warrant

SDSTW

Stardust Power Inc. Warrant

HOLD

Current Price

$0.10

Market Cap

3.4M

Sector

N/A

ML Signal

HOLD

Logo Virax Biolabs Group Limited

VRAX

Virax Biolabs Group Limited

HOLD

Current Price

$0.40

Market Cap

2.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SDSTW
VRAX
Founded
N/A
2013
Country
United States
United Kingdom
Employees
8
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.4M
2.9M
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
SDSTW
VRAX
Price
$0.10
$0.40
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$3.00
AVG Volume (30 Days)
41.6K
15.4M
Earning Date
03-26-2025
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$2,986.00
Revenue This Year
N/A
$217,274.83
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.10
$0.35
52 Week High
$0.12
$3.20

Technical Indicators

Market Signals
Indicator
SDSTW
VRAX
Relative Strength Index (RSI) 35.05 41.23
Support Level $0.11 $0.39
Resistance Level $0.17 $0.43
Average True Range (ATR) 0.01 0.07
MACD -0.00 -0.01
Stochastic Oscillator 6.10 3.23

Price Performance

Historical Comparison
SDSTW
VRAX

About SDSTW Stardust Power Inc. Warrant

Stardust Power Inc is developing a lithium refinery at its Facility in Muskogee, Oklahoma, with planned capacity of producing up to 50,000 metric tons per annum of BGLC once fully operational. The company will source lithium brine feedstock from various suppliers and may make investments upstream to secure additional feedstock. The Company seeks to sell its products to electric vehicle (EV) manufacturers as the primary market, with potential applications in other areas such as battery manufacturers, the U.S. military, and original equipment manufacturers (OEMs).

About VRAX Virax Biolabs Group Limited

Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes (HSV-1) and Human Papillomavirus (HPV).

Share on Social Networks: